If you add two doubles (100% + 100% on top) you get 300% potential by this summer. 6 to 24, and that's just a start.
pianoman
Seen it before on another stock Jesse -
07/15/2009 - 2.53 - 2.85 - 2.53 - 2.75 - 7,890,613
07/08/2009 - 2.65 - 2.67 - 2.25 - 2.39 - 7,129,992
07/01/2009 - 3.05 - 3.05 - 2.87 - 2.92 - 4,859,325
06/24/2009 - 2.50 - 2.87 - 2.50 - 2.70 - 6,776,820
06/17/2009 - 2.54 - 2.54 - 2.23 - 2.37 - 4,596,816
06/10/2009 - 2.81 - 2.85 - 2.65 - 2.71 - 3,244,967
06/03/2009 - 2.63 - 3.14 - 2.53 - 3.03 - 10,264,590
05/27/2009 - 2.00 - 2.08 - 1.96 - 2.03 - 2,288,427
05/20/2009 - 2.05 - 2.08 - 1.98 - 2.00 - 2,009,725
05/13/2009 - 1.91 - 1.94 - 1.67 - 1.88 - 4,113,200
05/06/2009 - 2.01 - 2.32 - 1.91 - 2.13 - 5,488,839
04/29/2009 - 1.35 - 1.42 - 1.30 - 1.39 - 3,586,157
04/22/2009 - 1.22 - 1.30 - 1.21 - 1.23 - 1,841,754
04/15/2009 - 1.10 - 1.48 - 1.07 - 1.41 - 7,928,979
04/08/2009 - 0.83 - 0.84 - 0.81 - 0.83 - 810,977
04/01/2009 - 0.85 - 0.89 - 0.80 - 0.85 - 1,033,640
03/25/2009 - 0.86 - 0.90 - 0.84 - 0.86 - 2,630,082
03/18/2009 - 0.77 - 0.94 - 0.74 - 0.90 - 3,739,392
03/11/2009 - 0.57 - 0.57 - 0.45 - 0.48 - 7,698,879
And it was only the start in that case as well -
"ROCKVILLE, Maryland, and LONDON, UK – July 20, 2009 – Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab, formerly LymphoStat-B®) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE)."
great call..great info
Here's what happened after those encouraging Phase III results.
Anybody assuming that the INSM share price is unlikely to exceed two or three times the current price over the next few months could be making an expensive assumption -
Date ----------- Open -- High --- Low --- Close --- Volume
12/23/2009 - 30.85 - 31.40 - 30.55 - 30.75 - 4,746,144
12/16/2009 - 28.30 - 28.66 - 27.96 - 28.33 - 2,796,200
12/09/2009 - 27.51 - 27.69 - 26.76 - 27.11 - 3,555,438
12/02/2009 - 26.83 - 27.56 - 26.78 - 27.46 - 3,564,268
11/25/2009 - 28.08 - 28.20 - 27.47 - 27.96 - 2,669,918
11/18/2009 - 28.50 - 28.70 - 27.77 - 27.84 - 4,661,150
11/11/2009 - 28.80 - 29.48 - 28.24 - 28.51 - 4,908,632
11/04/2009 - 27.61 - 28.19 - 26.24 - 26.48 - 12,487,950
10/28/2009 - 19.30 - 19.37 - 17.83 - 18.01 - 8,588,417
10/21/2009 - 19.83 - 20.40 - 18.94 - 19.08 - 7,083,437
10/14/2009 - 19.03 - 19.22 - 18.82 - 19.16 - 7,077,614
10/07/2009 - 19.45 - 19.65 - 18.64 - 18.96 - 4,982,780
09/30/2009 - 19.11 - 19.26 - 18.51 - 18.82 - 5,144,892
09/23/2009 - 19.50 - 19.54 - 18.80 - 18.87 - 4,692,131
09/16/2009 - 20.04 - 20.30 - 19.77 - 19.90 - 4,546,353
09/09/2009 - 19.49 - 19.75 - 19.26 - 19.61 - 5,215,776
09/02/2009 - 18.47 - 18.56 - 17.36 - 17.46 - 10,211,830
08/26/2009 - 22.00 - 22.78 - 19.42 - 20.50 - 39,614,900
08/19/2009 - 15.25 - 15.95 - 15.25 - 15.86 - 5,616,838
08/12/2009 - 15.85 - 16.50 - 15.76 - 16.21 - 8,721,898
08/05/2009 - 15.16 - 15.18 - 14.58 - 14.90 - 6,429,720
07/29/2009 - 14.32 - 15.45 - 14.15 - 14.71 - 29,962,190
07/22/2009 - 14.50 - 14.83 - 13.35 - 14.05 - 33,920,750
My expectation is $30+ in July while waiting on NTM results.
Wild card is IPLEX/Premiplex.
Wow, that post struch a chord!
pianoman
not saying it is but what if the old iplex/hars study for aids was involved with the only cure of aids in a child that has been on the news all morning.